The rise of post-prandial GLP-1 secretion after Roux-en-Y gastric bypass (RYGB) may improve metabolic parameters in type 2 diabetes (T2D) individuals [2–6]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.